Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

During sleep, the muscle tonus in the oropharyngeal space is lost, the tongue might fall back andthe volume of the pharynx decreases. Air cannot pass through as it would in the awake state and thus airflow limitations occur. The person asleep might compensate the flow limitation by breathing faster, which causes the soft tissue to vibrate (= snoring). Further narrowing of the airways can lead to obstructive apneas (complete airway collapse and stopping of airflow). First line therapy for obstructive sleep apnea (OSA) is positive airway pressure (PAP) that keeps the airways open with a pneumatic splint. Since PAP involves wearing a facial mask that applies air pressure into the airways, some patients cannot tolerate this therapy. These patients might be candidates for an alternative treatment approach with a mandibular advancement device (MAD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Prescription of any mandibular advancement device

• Age ≥ 18 years

• Ability to understand the study information and information on usage of personal data

• Signed and dated informed consent

Locations
Other Locations
Germany
Zentrum für Schlafmedizin Dr. Warmuth
NOT_YET_RECRUITING
Berlin
Schlaf- und Beatmungszentrum Blaubeuren
NOT_YET_RECRUITING
Blaubeuren Abbey
Ruhrlandklinik Essen
RECRUITING
Essen
Universitätsklinikum Regensburg - Klinik für Innere Medizin II
NOT_YET_RECRUITING
Regensburg
Contact Information
Primary
Oliver Munt, PhD
oliver.munt@resmed.de
+491629056360
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: ResMed

This content was sourced from clinicaltrials.gov